BioCentury
ARTICLE | Company News

Applied Molecular Transport, J&J deal

February 2, 2015 8:00 AM UTC

Applied Molecular Transport granted Johnson & Johnson’s Janssen Biotech Inc. unit exclusive, worldwide rights to an undisclosed preclinical oral candidate, which is in development to treat inflammator...